Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
US 7,307,166 Lapsed on the fee recordLapsed Dec 11, 2019 on the fee record · From the USPTO record
20-year base term ended Dec 11, 2024
Third maintenance fee unpaid; grace period ended.
Oct 28, 1987
Dec 11, 2019
Dec 11, 2007
Dec 11, 2024
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, the 1995 transition rule | Granted Dec 11, 2007 + 17 years, or clock starts Oct 28, 1987 + 20 years, whichever is later; a parent in its chain could not be resolved (the next row) | Dec 11, 2024 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | No term adjustment record on a grant after 2005, so none is added | no change | Medium confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Dec 11, 2019 | High confidence |
| Computed term end | The steps above, in order | Dec 11, 2019 | From the USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.